181 related articles for article (PubMed ID: 24462112)
21. The p53 response to DNA damage.
Meek DW
DNA Repair (Amst); 2004; 3(8-9):1049-56. PubMed ID: 15279792
[TBL] [Abstract][Full Text] [Related]
22. Discovery of a Potent and Selective Degrader for USP7.
Pei Y; Fu J; Shi Y; Zhang M; Luo G; Luo X; Song N; Mi T; Yang Y; Li J; Zhou Y; Zhou B
Angew Chem Int Ed Engl; 2022 Aug; 61(33):e202204395. PubMed ID: 35691827
[TBL] [Abstract][Full Text] [Related]
23. Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death.
Lee JH; Kim HS; Lee SJ; Kim KT
J Cell Sci; 2007 Jul; 120(Pt 13):2259-71. PubMed ID: 17591690
[TBL] [Abstract][Full Text] [Related]
24. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
Lu X; Ma O; Nguyen TA; Jones SN; Oren M; Donehower LA
Cancer Cell; 2007 Oct; 12(4):342-54. PubMed ID: 17936559
[TBL] [Abstract][Full Text] [Related]
25. JAK2(V617F) negatively regulates p53 stabilization by enhancing MDM2 via La expression in myeloproliferative neoplasms.
Nakatake M; Monte-Mor B; Debili N; Casadevall N; Ribrag V; Solary E; Vainchenker W; Plo I
Oncogene; 2012 Mar; 31(10):1323-33. PubMed ID: 21785463
[TBL] [Abstract][Full Text] [Related]
26. SUMO-specific protease SUSP4 positively regulates p53 by promoting Mdm2 self-ubiquitination.
Lee MH; Lee SW; Lee EJ; Choi SJ; Chung SS; Lee JI; Cho JM; Seol JH; Baek SH; Kim KI; Chiba T; Tanaka K; Bang OS; Chung CH
Nat Cell Biol; 2006 Dec; 8(12):1424-31. PubMed ID: 17086174
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of p53 degradation.
Chao CC
Clin Chim Acta; 2015 Jan; 438():139-47. PubMed ID: 25172038
[TBL] [Abstract][Full Text] [Related]
28. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.
Moumen A; Masterson P; O'Connor MJ; Jackson SP
Cell; 2005 Dec; 123(6):1065-78. PubMed ID: 16360036
[TBL] [Abstract][Full Text] [Related]
29. Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation.
Stommel JM; Wahl GM
EMBO J; 2004 Apr; 23(7):1547-56. PubMed ID: 15029243
[TBL] [Abstract][Full Text] [Related]
30. Modulation of p53 degradation via MDM2-mediated ubiquitylation and the ubiquitin-proteasome system during reperfusion after stroke: role of oxidative stress.
Saito A; Hayashi T; Okuno S; Nishi T; Chan PH
J Cereb Blood Flow Metab; 2005 Feb; 25(2):267-80. PubMed ID: 15678128
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
Ghosh M; Huang K; Berberich SJ
Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
[TBL] [Abstract][Full Text] [Related]
32. Hyperubiquitylation of wild-type p53 contributes to cytoplasmic sequestration in neuroblastoma.
Becker K; Marchenko ND; Maurice M; Moll UM
Cell Death Differ; 2007 Jul; 14(7):1350-60. PubMed ID: 17380154
[TBL] [Abstract][Full Text] [Related]
33. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress.
Grönroos E; Terentiev AA; Punga T; Ericsson J
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12165-70. PubMed ID: 15295102
[TBL] [Abstract][Full Text] [Related]
34. Mdm2 ligase dead mutants did not act in a dominant negative manner to re-activate p53, but promoted tumor cell growth.
Swaroop M; Sun Y
Anticancer Res; 2003; 23(4):3167-74. PubMed ID: 12926050
[TBL] [Abstract][Full Text] [Related]
35. HMG-CoA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage.
Pääjärvi G; Roudier E; Crisby M; Högberg J; Stenius U
FASEB J; 2005 Mar; 19(3):476-8. PubMed ID: 15625077
[TBL] [Abstract][Full Text] [Related]
36. USP7/HAUSP stimulates repair of oxidative DNA lesions.
Khoronenkova SV; Dianova II; Parsons JL; Dianov GL
Nucleic Acids Res; 2011 Apr; 39(7):2604-9. PubMed ID: 21138959
[TBL] [Abstract][Full Text] [Related]
37. (1)H, (13)C and (15)N backbone resonance assignment for the 40.5 kDa catalytic domain of Ubiquitin Specific Protease 7 (USP7).
Di Lello P; Rougé L; Pan B; Maurer T
Biomol NMR Assign; 2016 Oct; 10(2):345-9. PubMed ID: 27386854
[TBL] [Abstract][Full Text] [Related]
38. The stability of epigenetic factor ASXL1 is regulated through ubiquitination and USP7-mediated deubiquitination.
Inoue D; Nishimura K; Kozuka-Hata H; Oyama M; Kitamura T
Leukemia; 2015 Nov; 29(11):2257-60. PubMed ID: 25836587
[No Abstract] [Full Text] [Related]
39. Regulation of p53 and MDM2 activity by MTBP.
Brady M; Vlatkovic N; Boyd MT
Mol Cell Biol; 2005 Jan; 25(2):545-53. PubMed ID: 15632057
[TBL] [Abstract][Full Text] [Related]
40. Stabilization of LSD1 by deubiquitinating enzyme USP7 promotes glioblastoma cell tumorigenesis and metastasis through suppression of the p53 signaling pathway.
Yi L; Cui Y; Xu Q; Jiang Y
Oncol Rep; 2016 Nov; 36(5):2935-2945. PubMed ID: 27632941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
